News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
12,678 Results
Type
Article (714)
Company Profile (19)
Press Release (11945)
Section
Business (4472)
Career Advice (15)
Deals (650)
Drug Delivery (2)
Drug Development (2327)
Employer Resources (2)
FDA (200)
Job Trends (264)
News (7192)
Policy (379)
Tag
Academia (37)
Adcomms (3)
Allergies (2)
Alliances (1199)
Alzheimer's disease (10)
Antibody-drug conjugate (ADC) (5)
Approvals (200)
Artificial intelligence (2)
Bankruptcy (3)
Best Places to Work (212)
BIOSECURE Act (4)
Biotechnology (15)
Cancer (29)
Cardiovascular disease (3)
Career advice (10)
CAR-T (6)
Cell therapy (17)
Clinical research (1729)
Collaboration (11)
Compensation (5)
COVID-19 (100)
CRISPR (4)
C-suite (4)
Data (21)
Diabetes (2)
Diagnostics (28)
Earnings (1363)
Events (2320)
Executive appointments (9)
FDA (212)
Featured Employer (3)
Funding (13)
Gene editing (7)
Gene therapy (12)
GLP-1 (18)
Government (43)
Healthcare (384)
Infectious disease (101)
Inflammatory bowel disease (6)
Intellectual property (3)
Interviews (3)
IPO (354)
Job creations (62)
Job search strategy (10)
Layoffs (8)
Legal (64)
Lymphoma (4)
Manufacturing (7)
Medical device (63)
Medtech (63)
Mergers & acquisitions (304)
Metabolic disorders (5)
Neuroscience (12)
NextGen Class of 2024 (139)
Non-profit (19)
Northern California (51)
Obesity (3)
Pain (2)
Patents (7)
Patient recruitment (3)
People (1622)
Phase I (778)
Phase II (849)
Phase III (511)
Pipeline (8)
Policy (6)
Postmarket research (25)
Preclinical (258)
Prostate cancer (2)
Rare diseases (3)
Real estate (111)
Regulatory (300)
Research institute (62)
Resumes & cover letters (3)
Series A (5)
Southern California (49)
Startups (103)
United States (331)
Vaccines (11)
Date
Today (5)
Last 7 days (25)
Last 30 days (93)
Last 365 days (1049)
2024 (914)
2023 (1261)
2022 (1597)
2021 (1624)
2020 (1243)
2019 (738)
2018 (540)
2017 (663)
2016 (546)
2015 (592)
2014 (399)
2013 (343)
2012 (292)
2011 (296)
2010 (310)
Location
Africa (14)
Asia (1042)
Australia (88)
California (134)
Canada (43)
China (13)
Connecticut (5)
Europe (1240)
Florida (8)
Maryland (38)
Massachusetts (59)
Minnesota (4)
New Jersey (21)
New York (11)
North Carolina (13)
Northern California (51)
Pennsylvania (19)
South America (9)
Southern California (49)
Texas (7)
Washington State (7)
12,678 Results for "asterias biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FORE Biotherapeutics to Participate in Upcoming November Conferences
November 7, 2024
·
1 min read
Press Releases
Oxford BioTherapeutics to Present at World ADC Conference 2024
October 31, 2024
·
3 min read
Press Releases
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences
October 29, 2024
·
2 min read
SAb Biotherapeutics Rebrands as SAB BIO
SAB Biotherapeutics today announced its new name, SAB BIO, and visual identity to more closely align with its mission to treat and prevent immune and autoimmune disorders with the use of its unique immunotherapy platform.
June 20, 2024
·
5 min read
Press Releases
Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
October 18, 2024
·
4 min read
Business
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
October 22, 2024
·
4 min read
BioMidwest
Adolore BioTherapeutics to Present at the Virtual Investor Pitch Conference
Adolore BioTherapeutics, a biotechnology company focused on developing breakthrough opioid-free gene therapy treatments for chronic pain, announced that it will present at the Virtual Investor Pitch Conference on June 17, 2024 at 10:00 AM ET.
June 10, 2024
·
1 min read
Press Releases
Adolore BioTherapeutics to Present at BioSparkVA Pitch Event
September 25, 2024
·
3 min read
SAB Biotherapeutics Announces Departure of Chief Financial Officer
SAB Biotherapeutics today announced that effective June 4, its Chief Financial Officer Michael King will be departing the company to accept a role as CEO at a privately-held oncology company.
May 30, 2024
·
4 min read
Press Releases
Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences
October 25, 2024
·
5 min read
1 of 1,268
Next
